Weill Medical College Of Cornell University
Clinical trials sponsored by Weill Medical College Of Cornell University, explained in plain language.
-
New drug combo trial for Hard-to-Treat lymphoma shows early promise
Disease control TerminatedThis early-phase trial tested a combination of two oral drugs, tazemetostat and venetoclax, in people with Non-Hodgkin lymphoma that had returned or stopped responding to treatment. The main goals were to find the safest dose and understand side effects. Only 3 participants were …
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 01, 2026 13:44 UTC
-
Experimental brain tumor treatment halted after just one patient
Disease control TerminatedThis early-stage study tested giving chemotherapy directly into the brain's arteries to shrink rare choroid plexus tumors before a second surgery. Only one person took part before the study was stopped. The goal was to see if the approach was safe and could make tumors smaller fo…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New antibiotic tackles tough infections in vulnerable patients
Disease control TerminatedThis study looked at whether the antibiotic ceftolozane-tazobactam can treat serious Pseudomonas infections in people with blood cancers or who had a stem cell transplant. Participants received the drug through a vein for 10 to 14 days. Researchers tracked survival and infection …
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC